{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:09:44Z","timestamp":1783739384805,"version":"3.55.0"},"reference-count":101,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Polymers"],"abstract":"<jats:p>Atherosclerosis-related coronary artery disease (CAD) is one of the leading sources of mortality and morbidity in the world. Primary and secondary prevention appear crucial to reduce CAD-related complications. In this scenario, statin treatment was shown to be clinically effective in the reduction of adverse events, but systemic administration provides suboptimal results. As an attempt to improve bioavailability and effectiveness, polymers and nanoparticles for statin delivery were recently investigated. Polymers and nanoparticles can help statin delivery and their effects by increasing oral bioavailability or enhancing target-specific interaction, leading to reduced vascular endothelial dysfunction, reduced intimal hyperplasia, reduced ischemia-reperfusion injury, increased cardiac regeneration, positive remodeling in the extracellular matrix, reduced neointimal growth and increased re-endothelization. Moreover, some innovative aspects described in other cardiovascular fields could be translated into the CAD scenario. Recent preclinical studies are underlining the effect of statins in the stimulation and differentiation of endogenous cardiac stem cells, as well as in targeting of local adverse conditions implicated in atherosclerosis, and statin delivery through poly-lactic-co-glycolic acid (PLGA) appears the most promising aspect of current research to enhance drug activity. The present review intends to summarize the current evidence about polymers and nanoparticles for statin delivery in the field of cardiovascular disease, trying to shed light on this topic and identify new avenues for future studies.<\/jats:p>","DOI":"10.3390\/polym13050711","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T09:47:20Z","timestamp":1614332840000},"page":"711","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Polymers and Nanoparticles for Statin Delivery: Current Use and Future Perspectives in Cardiovascular Disease"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-6781","authenticated-orcid":false,"given":"Antonio","family":"Nenna","sequence":"first","affiliation":[{"name":"Cardiovascular Surgery, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Nappi","sequence":"additional","affiliation":[{"name":"Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, 93200 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Larobina","sequence":"additional","affiliation":[{"name":"Institute for Polymers, Composites and Biomaterials, National Research Council of Italy, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Verghi","sequence":"additional","affiliation":[{"name":"Cardiovascular Surgery, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Chello","sequence":"additional","affiliation":[{"name":"Cardiovascular Surgery, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ambrosio","sequence":"additional","affiliation":[{"name":"Institute for Polymers, Composites and Biomaterials, National Research Council of Italy, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jacc.2019.07.062","article-title":"From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient: JACC State-of-the-Art Review","volume":"74","author":"Fuster","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41401-020-0436-0","article-title":"Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis","volume":"42","author":"Ou","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(19)31794-5","article-title":"Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: A prospective, cohort study","volume":"394","author":"Waksman","year":"2019","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"E781","DOI":"10.1152\/ajpendo.00218.2016","article-title":"25-Hydroxycholesterol impairs endothelial function and vasodilation by uncoupling and inhibiting endothelial nitric oxide synthase","volume":"311","author":"Ou","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","article-title":"Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice","volume":"558","author":"Que","year":"2018","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"111161","DOI":"10.1016\/j.mad.2019.111161","article-title":"Changes of the coronary arteries and cardiac microvasculature with aging: Implications for translational research and clinical practice","volume":"184","author":"Piccirillo","year":"2019","journal-title":"Mech. Ageing Dev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic Effects of Statins on the Cardiovascular System","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zu, Y., Dhanasekara, C.S., Li, J., Wu, D., Fan, Z., and Wang, S. (2017). Detection and treatment of atherosclerosis using nanoparticles. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 9.","DOI":"10.1002\/wnan.1412"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/ATVBAHA.118.311569","article-title":"Nanoparticle Therapy for Vascular Diseases","volume":"39","author":"Flores","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.5551\/jat.35113","article-title":"Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases","volume":"23","author":"Koga","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fcvm.2017.00087","article-title":"Anti-inflammatory Nanomedicine for Cardiovascular Disease","volume":"4","author":"Katsuki","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Fukuhara, N., Honda, Y., Ukita, N., Matsui, M., Miura, Y., and Hoshina, K. (2020). Efficient Suppression of Abdominal Aortic Aneurysm Expansion in Rats through Systemic Administration of Statin-Loaded Nanomedicine. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228702"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1021\/acs.chemrev.8b00199","article-title":"Block Copolymer Micelles in Nanomedicine Applications","volume":"118","author":"Cabral","year":"2018","journal-title":"Chem. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/jcp.27121","article-title":"Liposomal nanocarriers for statins: A pharmacokinetic and pharmacodynamics appraisal","volume":"234","author":"Askarizadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","article-title":"The pharmacology of statins","volume":"88","author":"Sirtori","year":"2014","journal-title":"Pharmacol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"120077","DOI":"10.1016\/j.ijpharm.2020.120077","article-title":"Enhancement of atorvastatin oral bioavailability via encapsulation in polymeric nanoparticles","volume":"592","author":"Shaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"118891","DOI":"10.1016\/j.ijpharm.2019.118891","article-title":"Improved solubility, dissolution, and oral bioavailability for atorvastatin-Pluronic(R) solid dispersions","volume":"574","author":"Shaker","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2009.02.015","article-title":"Micronization of atorvastatin calcium by antisolvent precipitation process","volume":"374","author":"Zhang","year":"2009","journal-title":"Int. J. Pharm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijpharm.2008.04.006","article-title":"Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process","volume":"359","author":"Kim","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_20","first-page":"241","article-title":"Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats","volume":"44","author":"Anwar","year":"2011","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijbiomac.2013.03.068","article-title":"Oral absorption of atorvastatin solid dispersion based on cellulose or pyrrolidone derivative polymers","volume":"59","author":"Kim","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.powtec.2015.08.047","article-title":"Pharmacological and histological examination of atorvastatin-PVP K30 solid dispersions","volume":"286","author":"Jahangiri","year":"2015","journal-title":"Powder Technol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jddst.2015.11.003","article-title":"Atorvastatin\u2013cyclodextrin systems: Physiochemical and biopharmaceutical evaluation","volume":"31","author":"Palanisamy","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1773-2247(12)50089-4","article-title":"Design and development of atorvastatin calcium buccoadhesive bilayered devices for oral drug delivery","volume":"22","author":"Ramani","year":"2012","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1208\/s12249-011-9673-3","article-title":"Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation","volume":"12","author":"Khan","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3797\/scipharm.1104-26","article-title":"Enhanced Bioavailability and Dissolution of Atorvastatin Calcium from Floating Microcapsules using Minimum Additives","volume":"80","author":"Khan","year":"2012","journal-title":"Sci. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2016.03.045","article-title":"PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-epsilon-caprolactone nanoparticles","volume":"504","author":"Ahmed","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"16520","DOI":"10.1039\/C5RA26674B","article-title":"Atorvastatin calcium loaded PCL nanoparticles: Development, optimization, in vitro and in vivo assessments","volume":"6","author":"Kumar","year":"2016","journal-title":"RSC Adv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajps.2016.08.006","article-title":"The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration in vitro and in vivo","volume":"12","author":"Li","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.sjbs.2017.03.015","article-title":"Nano-particle engineered atorvastatin delivery to support mesenchymal stem cell survival in infarcted myocardium","volume":"25","author":"Yao","year":"2018","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.nano.2014.02.014","article-title":"Intestinal absorption of insulin nanoparticles: Contribution of M cells","volume":"10","author":"Lopes","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_32","first-page":"100023","article-title":"Premium ethylcellulose polymer based architectures at work in drug delivery","volume":"1","author":"Adeleke","year":"2019","journal-title":"Int. J. Pharm. X"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Shokri, J., and Adibkia, K. (2013). Application of Cellulose and Cellulose Derivatives in Pharmaceutical Industries. Cellul. Med. Pharm. Electron. Appl., 47\u201366.","DOI":"10.5772\/55178"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wasilewska, K., and Winnicka, K. (2019). Ethylcellulose\u2014A Pharmaceutical Excipient with Multidirectional Application in Drug Dosage Forms Development. Materials, 12.","DOI":"10.3390\/ma12203386"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijpharm.2018.11.061","article-title":"Mechanical particle coating using ethylcellulose nanoparticle agglomerates for preparing controlled release fine particles; effect of coating temperature on coating performance","volume":"554","author":"Kondo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12012-018-9491-x","article-title":"Nano-medicine and Vascular Endothelial Dysfunction: Options and Delivery Strategies","volume":"19","author":"Taneja","year":"2019","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tcm.2006.11.005","article-title":"Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury","volume":"17","author":"Papaharalambus","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1021\/acs.chemrev.5b00116","article-title":"Clinical Translation of Nanomedicine","volume":"115","author":"Min","year":"2015","journal-title":"Chem. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.14797\/mdcj-12-3-169","article-title":"Vascular Inflammation: A Novel Access Route for Nanomedicine","volume":"12","author":"Molinaro","year":"2016","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tox.2007.12.011","article-title":"Potential target sites to modulate vascular endothelial dysfunction: Current perspectives and future directions","volume":"245","author":"Balakumar","year":"2008","journal-title":"Toxicology"},{"key":"ref_41","first-page":"e26949","article-title":"Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease","volume":"4","author":"Nenna","year":"2015","journal-title":"Res. Cardiovasc. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1574890110666151104120039","article-title":"Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications","volume":"10","author":"Nenna","year":"2015","journal-title":"Recent Adv. Cardiovasc. Drug Discov."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/bph.13517","article-title":"Targeting vascular (endothelial) dysfunction","volume":"174","author":"Daiber","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"j909","DOI":"10.1136\/bmj.j909","article-title":"Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: Population based cohort study using linked health records","volume":"356","author":"Bell","year":"2017","journal-title":"BMJ"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/FJC.0b013e3181624aed","article-title":"Inhibition of macrophage phagocytotic activity by a receptor-targeted polymer vesicle-based drug delivery formulation of pravastatin","volume":"51","author":"Broz","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1038\/ncomms4065","article-title":"A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation","volume":"5","author":"Duivenvoorden","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e1400223","DOI":"10.1126\/sciadv.1400223","article-title":"Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation","volume":"1","author":"Tang","year":"2015","journal-title":"Sci. Adv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.113.002870","article-title":"Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization\/rupture in mice by regulating the recruitment of inflammatory monocytes","volume":"129","author":"Katsuki","year":"2014","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","article-title":"Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines","volume":"11","author":"Gao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1753944710362903","article-title":"The role of endothelial cells and their progenitors in intimal hyperplasia","volume":"4","author":"Patel","year":"2010","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e001472","DOI":"10.1161\/JAHA.114.001472","article-title":"Local association between endothelial dysfunction and intimal hyperplasia: Relevance in peripheral artery disease","volume":"4","author":"Heinen","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/1538574419833224","article-title":"Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury","volume":"53","author":"Helkin","year":"2019","journal-title":"Vasc. Endovasc. Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1538574410362922","article-title":"Basic science review: Statin therapy\u2014Part I: The pleiotropic effects of statins in cardiovascular disease","volume":"44","author":"Sadowitz","year":"2010","journal-title":"Vasc. Endovasc. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00595-008-3912-6","article-title":"Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase\/nitric oxide (eNOS\/NO) and the Rho\/Rho-kinase pathway","volume":"39","author":"Sugimoto","year":"2009","journal-title":"Surg. Today"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/cvr\/cvq129","article-title":"Postconditioning and protection from reperfusion injury: Where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology","volume":"87","author":"Ovize","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_57","first-page":"1643","article-title":"Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property","volume":"70","author":"Matsuki","year":"2006","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ccd.23449","article-title":"Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial","volume":"80","author":"Post","year":"2012","journal-title":"Catheter. Cardiovasc. Interv. Off. J. Soc. Card. Angiogr. Interv."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jvs.2010.03.020","article-title":"Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia","volume":"52","author":"Oda","year":"2010","journal-title":"J. Vasc. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.108.182584","article-title":"Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium","volume":"29","author":"Kubo","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","article-title":"PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect","volume":"63","author":"Acharya","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Nagaoka, K., Matoba, T., Mao, Y., Nakano, Y., Ikeda, G., Egusa, S., Tokutome, M., Nagahama, R., Nakano, K., and Sunagawa, K. (2015). A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K\/Akt Pathway and Anti-Inflammation in a Rat Model. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132451"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Ichimura, K., Matoba, T., Nakano, K., Tokutome, M., Honda, K., Koga, J., and Egashira, K. (2016). A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162425"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Cianflone, E., Cappetta, D., Mancuso, T., Sabatino, J., Marino, F., Scalise, M., Albanese, M., Salatino, A., Parrotta, E.I., and Cuda, G. (2020). Statins Stimulate New Myocyte Formation After Myocardial Infarction by Activating Growth and Differentiation of the Endogenous Cardiac Stem Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217927"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/01.RES.0000117306.10142.50","article-title":"Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression","volume":"94","author":"Torella","year":"2004","journal-title":"Circ. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.175943","article-title":"Aging and disease as modifiers of efficacy of cell therapy","volume":"102","author":"Dimmeler","year":"2008","journal-title":"Circ. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/sctm.18-0244","article-title":"Cardiac Regeneration by Statin-Polymer Nanoparticle-Loaded Adipose-Derived Stem Cell Therapy in Myocardial Infarction","volume":"8","author":"Yokoyama","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.RES.0000109792.43271.47","article-title":"Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells","volume":"94","author":"Menard","year":"2004","journal-title":"Circ. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/labinvest.2010.191","article-title":"Synergistic effect of adipose-derived stem cell therapy and bone marrow progenitor recruitment in ischemic heart","volume":"91","author":"Li","year":"2011","journal-title":"Lab. Investig. A J. Tech. Methods Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","article-title":"Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells","volume":"109","author":"Rehman","year":"2004","journal-title":"Circulation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/cvr\/cvp267","article-title":"Spontaneously beating cardiomyocytes derived from white mature adipocytes","volume":"85","author":"Jumabay","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ehf2.12509","article-title":"Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts","volume":"6","author":"Emelyanova","year":"2019","journal-title":"ESC Heart Fail."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbadis.2012.12.007","article-title":"Strategies for anti-fibrotic therapies","volume":"1832","author":"Rosenbloom","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2014.08.001","article-title":"Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: Regulation and therapeutic implications","volume":"75","author":"Ichiki","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yjmcc.2015.12.024","article-title":"The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction","volume":"91","author":"Lindsey","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2013.11.015","article-title":"Fibroblasts in myocardial infarction: A role in inflammation and repair","volume":"70","author":"Shinde","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1536\/ihj.16-457","article-title":"Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes\/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation","volume":"58","author":"Mao","year":"2017","journal-title":"Int. Heart J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/ATVBAHA.115.307057","article-title":"Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte\/Macrophage Differentiation in ApoE-\/- Mice","volume":"36","author":"Nakashiro","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1536\/ihj.17-303","article-title":"Can Statins Modify the Wound Healing Process After Myocardial Infarction?","volume":"58","author":"Hasegawa","year":"2017","journal-title":"Int. Heart J."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Lampi, M.C., Faber, C.J., Huynh, J., Bordeleau, F., Zanotelli, M.R., and Reinhart-King, C.A. (2016). Simvastatin Ameliorates Matrix Stiffness-Mediated Endothelial Monolayer Disruption. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147033"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2007.09.013","article-title":"Nano\/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives","volume":"125","author":"Mundargi","year":"2008","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Reichert, K., do Carmo, H.R.P., Galluce Torina, A., de Carvalho, D.D., Carvalho Sposito, A., de Souza Vilarinho, K.A., da Mota Silveira-Filho, L., Martins de Oliveira, P.P., and Petrucci, O. (2016). Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166845"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00395-016-0534-9","article-title":"Cells and extracellular matrix interplay in cardiac valve disease: Because age matters","volume":"111","author":"Spadaccio","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Nappi, F., Nenna, A., Larobina, D., Martuscelli, G., Singh, S.S., Chello, M., and Ambrosio, L. (2021). The Use of Bioactive Polymers for Intervention and Tissue Engineering: The New Frontier for Cardiovascular Therapy. Polymers, 13.","DOI":"10.3390\/polym13030446"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/cvr\/cvz214","article-title":"Preventing treatment failures in coronary artery disease: What can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries?","volume":"116","author":"Spadaccio","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2015.03.286","article-title":"Blockade of mTOR pathway inhibition in the neointimal hyperplasia and promoting macrophage autophagy\u2014Effect of statin-eluting stents to reduce in-stent restenosis","volume":"187","author":"Hu","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.atherosclerosis.2014.01.040","article-title":"mTOR inhibition: A promising strategy for stabilization of atherosclerotic plaques","volume":"233","author":"Martinet","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_88","first-page":"832","article-title":"Effectiveness of statin-eluting stent on early inflammatory response and neointimal thickness in a porcine coronary model","volume":"72","author":"Miyauchi","year":"2008","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jbm.b.32869","article-title":"Comparison of bare metal and statin-coated coils on rates of intra-aneurysmal tissue organization in a rat model of aneurysm","volume":"101","author":"Kodama","year":"2013","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4068\/cmj.2013.49.3.118","article-title":"Effect of atorvastatin-eluting stents in a rabbit iliac artery restenosis model","volume":"49","author":"Lim","year":"2013","journal-title":"Chonnam Med J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5551\/jat.13862","article-title":"Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model","volume":"20","author":"Tsukie","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2217\/fca-2019-0076","article-title":"Role of autophagy in aneurysm and dissection of the ascending aorta","volume":"16","author":"Lusini","year":"2020","journal-title":"Future Cardiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3400\/avd.ra.19-00130","article-title":"Therapeutic Arteriogenesis\/Angiogenesis for Peripheral Arterial Disease by Nanoparticle-Mediated Delivery of Pitavastatin into Vascular Endothelial Cells","volume":"13","author":"Matsumoto","year":"2020","journal-title":"Ann. Vasc. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"41012","DOI":"10.1021\/acsami.8b11714","article-title":"Rosuvastatin- and Heparin-Loaded Poly(l-lactide- co-caprolactone) Nanofiber Aneurysm Stent Promotes Endothelialization via Vascular Endothelial Growth Factor Type A Modulation","volume":"10","author":"Liu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"18067","DOI":"10.1038\/s41598-017-18286-x","article-title":"Pitavastatin nanoparticle-engineered endothelial progenitor cells repair injured vessels","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Nakamura, K., Akagi, S., Ejiri, K., Yoshida, M., Miyoshi, T., Toh, N., Nakagawa, K., Takaya, Y., Matsubara, H., and Ito, H. (2019). Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235885"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1536\/ihj.17-683","article-title":"Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats","volume":"59","author":"Ichimura","year":"2018","journal-title":"Int. Heart J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/HYPERTENSIONAHA.110.157032","article-title":"Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension","volume":"57","author":"Chen","year":"2011","journal-title":"Hypertension"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.nano.2016.05.002","article-title":"Preventive effects of simvastatin nanoliposome on isoproterenol-induced cardiac remodeling in mice","volume":"12","author":"Tuerdi","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6661847","article-title":"Effect of Statins on Platelet Activation and Function: From Molecular Pathways to Clinical Effects","volume":"2021","author":"Nenna","year":"2021","journal-title":"BioMed Res. Int."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jacc.2019.08.012","article-title":"From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review","volume":"74","author":"Ahmadi","year":"2019","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4360\/13\/5\/711\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:29:35Z","timestamp":1760160575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4360\/13\/5\/711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":101,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["polym13050711"],"URL":"https:\/\/doi.org\/10.3390\/polym13050711","relation":{},"ISSN":["2073-4360"],"issn-type":[{"value":"2073-4360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]}}}